Literature DB >> 20558224

Alpha3* and alpha 7 nAChR-mediated Ca2+ transient generation in IMR-32 neuroblastoma cells.

Hilde Ween1, Kirsten Thorin-Hagene, Elisabeth Andersen, Jens Halvard Grønlien, Chih-Hung Lee, Murali Gopalakrishnan, John Malysz.   

Abstract

Alpha3-containing (alpha 3*) and alpha 7 nicotinic acetylcholine receptors (nAChRs) are expressed in human IMR-32 neuroblastoma cells and implicated in Ca(2+) signaling. In this study, we investigated the intracellular Ca(2+) transient generation evoked by selective activation of alpha 3* (agonist potency rank order: epibatidine>varenicline>nicotine approximately cytisine) and alpha 7 (rank order in the presence of alpha 7 positive allosteric modulator or PAM: A-795723>NS6784 approximately PNU-282987) using, respectively, varenicline and NS6784 (+alpha 7 PAM) by Ca(2+) imaging. Effects of inhibitors of nAChRs (MLA and mecamylamine), ER Ca(2+) ATPase pump (CPA and thapsigargin), Ca(2+)-induced Ca(2+) release (ryanodine and dantrolene), Ca(2+) channels (nitrendipine, diltiazem, and Cd(2+)), and removal of extracellular Ca(2+) were examined. alpha 7 PAMs, when tested in the presence of NS6784, were more active when added first, followed by the agonist, than in the reverse order. Removal of extracellular Ca(2+) - but not CPA, thapsigargin, ryanodine, dantrolene, nitrendipine, diltiazem, or Cd(2+) - diminished the alpha 7 agonist-evoked Ca(2+) transients. In contrast, only diltiazem and nitrendipine and removal of extracellular Ca(2+) inhibited the alpha 3*-mediated Ca(2+) transients. The differential effect of diltiazem and nitrendipine versus Cd(2+) was due to direct inhibition of alpha 3* nAChRs as revealed by Ca(2+) imaging in HEK-293 cells expressing human alpha 3 beta 4 nAChRs and patch clamp in IMR-32 cells. In summary, this study provides evidence that alpha 3* and alpha 7 nAChR agonist-evoked global Ca(2+) transient generation in IMR-32 cells does not primarily involve voltage-dependent Ca(2+) channels, intracellular Ca(2+) stores, or Ca(2+)-induced Ca(2+) release. These mechanisms may, however, be still involved in other forms of nAChR-mediated Ca(2+) signaling. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20558224     DOI: 10.1016/j.neuint.2010.06.005

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  8 in total

Review 1.  Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations.

Authors:  Dustin K Williams; Jingyi Wang; Roger L Papke
Journal:  Biochem Pharmacol       Date:  2011-05-14       Impact factor: 5.858

2.  Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats.

Authors:  Luping Z Huang; Carla Campos; Jason Ly; F Ivy Carroll; Maryka Quik
Journal:  Neuropharmacology       Date:  2011-01-11       Impact factor: 5.250

3.  Single dose varenicline may trigger epileptic activity.

Authors:  Haydar Ali Erken; Gülten Erken; Hasan Simşek; Oğuzhan Korkut; Emine Rabia Koç; Ozlem Yavuz; Osman Genç
Journal:  Neurol Sci       Date:  2014-06-07       Impact factor: 3.307

4.  Nicotinic receptor agonists reduce L-DOPA-induced dyskinesias in a monkey model of Parkinson's disease.

Authors:  Danhui Zhang; Archana Mallela; David Sohn; F Ivy Carroll; Merouane Bencherif; Sharon Letchworth; Maryka Quik
Journal:  J Pharmacol Exp Ther       Date:  2013-07-31       Impact factor: 4.030

5.  Varenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatum.

Authors:  Tanuja Bordia; Maya Hrachova; Matthew Chin; J Michael McIntosh; Maryka Quik
Journal:  J Pharmacol Exp Ther       Date:  2012-05-01       Impact factor: 4.030

Review 6.  Alpha7 nicotinic receptors as therapeutic targets for Parkinson's disease.

Authors:  Maryka Quik; Danhui Zhang; Matthew McGregor; Tanuja Bordia
Journal:  Biochem Pharmacol       Date:  2015-06-18       Impact factor: 5.858

7.  Allosterically Potentiated α7 Nicotinic Acetylcholine Receptors: Reduced Calcium Permeability and Current-Independent Control of Intracellular Calcium.

Authors:  Douglas R Miller; Habibeh Khoshbouei; Sumanta Garai; Lucas N Cantwell; Clare Stokes; Ganesh Thakur; Roger L Papke
Journal:  Mol Pharmacol       Date:  2020-10-05       Impact factor: 4.436

8.  α-Conotoxin ImI-modified polymeric micelles as potential nanocarriers for targeted docetaxel delivery to α7-nAChR overexpressed non-small cell lung cancer.

Authors:  Dong Mei; Libo Zhao; Binlong Chen; Xiaoyan Zhang; Xiaoling Wang; Zhiying Yu; Xin Ni; Qiang Zhang
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.